R. Locigno et V. Castronovo, Reduced glutathione system: Role in cancer development, prevention and treatment (Review), INT J ONCOL, 19(2), 2001, pp. 221-236
Reduced glutathione (GSH), a ubiquitous thiolcontaining tripeptide, is unan
imously recognized to play a central role in cell biology. It is highly imp
licated in the cellular defense against xenobiotics and naturally occurring
deleterious compounds such as free radicals and hydroperoxides. Consequent
ly, GSH is an essential actor in several human diseases including cancer an
d cardio-vascular diseases. Its implication in oncogenesis has led to the d
evelopment of new strategies to improve both prevention and treatment of ca
ncer. The present review proposes an in depth analysis or our current knowl
edge of the relations between GSH and cancer.